Takeda to Present Multiple New Data Analyses at 2023 AAAAI Annual Meeting, Including SPRING Study of TAKHZYRO® (lanadelumab-flyo) in Pediatric Patients With Hereditary Angioedema (HAE)
Takeda Completes Acquisition of Nimbus Therapeutics’ TYK2 Program Subsidiary
SEE ALL NEWS AND RELEASES >
・For Shire news releases, click here
SEE ALL FEATURED TOPICS ARTICLES >
With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.